Successful biologics programs depend on making the right decisions at the right stage of development. Early choices in cell culture strategy, media and feed optimization, downstream recovery, analytical control strategy and scale-up approach can significantly affect yield, quality profile and manufacturing consistency later in the life cycle. In a competitive environment, development teams must balance speed, risk and platform fit while preserving flexibility for future process evolution.
This webinar will explore practical decision points across the biologics product life cycle, with emphasis on how process development, manufacturing science and quality systems can work as one integrated system. The featured speaker will examine how data packages, design space knowledge and risk-based planning support smoother technology transfer, reduce development risk and costly rework, improve process performance and enable faster GMP execution.
By connecting development decisions with downstream manufacturing requirements, the session will demonstrate how an integrated development-to-manufacturing approach can support reliable, reproducible and commercially relevant supply.
Register for this webinar to learn how product life cycle decisions can improve biologics process performance, technology transfer and GMP execution.
Who Should Attend
This webinar will appeal to:
Cell Culture, Upstream Process Development and Downstream Process Development professionals
Analytical Development and Analytical Sciences professionals
CMC leaders and Technical Program Managers
Regulatory Affairs and Regulatory CMC professionals
Quality, Compliance and Quality Systems leaders
Technical Operations, Manufacturing Science, MSAT and Technology Transfer teams
R&D Heads and Development Directors
Biologics, Peptide and Advanced Therapeutic Program leaders
Professionals responsible for process scale-up, manufacturing readiness and GMP execution
Decision-makers responsible for outsourcing strategy, CDMO partnerships, development acceleration and supply continuity
What You Will Learn
Attendees will gain insight into:
Early development decisions that affect process robustness, product quality, manufacturing cost, scalability and supply reliability
How integrated process, analytical, manufacturing and quality strategies can reduce development risk and avoid costly rework during technology transfer and GMP execution
How data-driven process understanding and design space knowledge enable more informed risk-based decisions and improve process performance throughout the product life cycle
How technology transfer should be designed into the development strategy from the beginning rather than treated as a separate downstream activity
How platform knowledge, manufacturing science and scalable process strategies can accelerate development while preserving flexibility for future process evolution
How an integrated development-to-manufacturing model can help sponsors translate development intent into reliable, reproducible and commercially relevant supply
Register free on Xtalks:
https://xtalks.com/webinars/reduce-biologics-development-risk-across-the-product-life-cycle/
